Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety
Work
Year: 2019
Type: article
Source: ChemMedChem
Institutions Cayman Chemical (United States), ARCA Biopharma (United States), Nanosyn (United States)
Cites: 15
Cited by: 67
Related to: 10
FWCI: 5.42
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed